Jeanette K Doorduijn

13PUBLICATIONS
86CO-AUTHORS
Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Central nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Primary central nervous system lymphoma-current standards and recent developments.

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Feb 04, 2026
Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Floriske G Stedema, Mirian Brink, Francien Huisman

|Nov 03, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Mouhamad Khouja, Elisa Genuardi, Simone Ferrero

|Apr 18, 2025
Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Marcel Nijland, Djamila E Issa, Johanna A A Bult

|Dec 19, 2023
Primary central nervous system lymphoma.

Myrthe E de Koning, Jurrit J Hof, Casper Jansen

Pageof 3

Frequent Collaborators

3 joint publications

Marcel Nijland

3 joint publications

Lina van der Straten

3 joint publications

Jacoline E C Bromberg

3 joint publications

Avinash G Dinmohamed